- The trend backdrop is active with a 5-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
HEALTHX
NSI
Week ended 07 Aug 2026
Weekly Investor Report
Health X Platform Limited · Healthcare · Pharmaceutical Retailers
Latest close
306.6 INR
-0.4%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is 3.9% above the Trend Line and sits at 49.0% of its 52-week range. The latest completed week returned -0.4%, after a -5.2% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 48/100.
Setup score
49
out of 100
Latest Close
306.6 INR
7 Aug 2026
1W Return
-0.4%
latest completed week
4W Return
-5.2%
short-term follow-through
12W Return
8.0%
quarterly tape
Trend Breadth
59.6%
31 of 52 weeks active
Volume Ratio
1.6x
vs 13-week average
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 41.19% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-0.4%
Latest completed week; four-week move -5.2%.
Indicator stack
50/60
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 41.19%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
48/100
15 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 3.9% above the Trend Line and sits at 49.0% of its 52-week range. The latest completed week returned -0.4%, after a -5.2% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.6x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.5712-week average 0.35
12-week confirmation
Trend active5/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.57Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -5.2% over four weeks, 8.0% over 12 weeks, and 7.1% over one year. The current trend has remained active for 5 consecutive weeks.
Performance by holding period
Active trend streak5 weeks
Active weeks in one year31
Trend breadth59.6%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.67Latest activity-pressure read.
Pressure change-22.0%Four-week change in activity pressure.
Leadership3.77Latest relative-leadership reading.
RS change-68.0%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 82%
Model confidence 77%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength20/100Blend of value, momentum, and quality. Underlying universe rank 81; rank 1 is best.
Value34/100Relative valuation strength. Underlying universe rank 67; rank 1 is best.
Quality2/100Profitability and accounting quality. Underlying universe rank 99; rank 1 is best.
Momentum73/100Medium-term price momentum. Underlying universe rank 28; rank 1 is best.
Growth72/100Revenue and earnings growth. Underlying universe rank 29; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 829.6x Price divided by trailing earnings.
- Price / sales
- 0.7x Market value relative to trailing revenue.
- EV / EBITDA
- 217.9x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- -8.1% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 7.6% Gross profit retained from each unit of revenue.
- Operating margin
- -5.4% Operating profit retained from revenue.
- Free-cash-flow margin
- -6.8% Free cash flow generated from revenue.
- Return on invested capital
- -8.3% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 20.0% Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 5/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- 0.0% Net share repurchases relative to market value.
- Shareholder yield
- 0.0% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- -0.9x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment48/100
Weighted news tone is neutral across 15 relevant articles.
2 positive · 9 neutral · 4 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-15.5%Distance below the 52-week high.
13-week volatility5.2%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher8 of 2617 weeks finished lower.
Best week+12.6%Week of 19 Jun.
Worst week-7.9%Week of 12 Jun.
Latest week-0.4%Week of 7 Aug.
Shape of recent returns
Strong gains4
Modest gains4
Flat weeks1
Modest losses13
Sharp losses4
Recent vol5.2%13-week weekly-return volatility.
Base vol4.1%52-week weekly-return volatility.
Up/down split21/30Count of positive and negative weeks in the 52-week window.
Average skew3.8% / -2.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIN Healthcare
4-week rank- / 100
Group average1.2%
Trend breadth83.0%
Trend83.0%active weekly trend signals
MD85.0%positive activity pressure
RS73.0%positive relative leadership
Four-week leaders
IndustryIN Pharmaceutical Retailers
4-week rank1 / 2
Group average-10.2%
Trend breadth50.0%
Trend50.0%active weekly trend signals
MD50.0%positive activity pressure
RS50.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape49/100
Trend, activity pressure, participation, and risk combine to a 49/100 tape read.
Indicator analysis69/100Latest 12-week confirmation: trend 5/12, activity pressure 12/12, relative leadership 12/12.
Activity pressure 0.57; No reversal markers Next-Week ExpectancyNegative 41.19%Next-week expectancy is negative with a 41.19% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors29/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Tiny Titans rank 20; Buyback Yield rank 36; Small Cap Core rank 69 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment48/100Weighted news tone is neutral across 15 relevant articles.
Xiamen Builds Multi-Dimensional Development Platform to Smooth the Path for Hong Kong and Macao Talent to Pursue Dreams in the City Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 306.6 INR | -0.4% | 295.1 INR | 310.6 INR | 0.67 | 3.77 | 49.4K | On |
| 31 Jul 2026 | 308.0 INR | -1.6% | 295.6 INR | 310.4 INR | 0.90 | 5.13 | 53.3K | On |
| 24 Jul 2026 | 312.9 INR | -1.5% | 295.8 INR | 310.1 INR | 0.87 | 9.76 | 23.7K | On |
| 17 Jul 2026 | 317.6 INR | -1.8% | 295.4 INR | 309.7 INR | 0.92 | 9.05 | 52.5K | On |
| 10 Jul 2026 | 323.3 INR | 3.5% | 295.0 INR | 309.4 INR | 0.86 | 11.77 | 77.1K | On |
| 3 Jul 2026 | 312.2 INR | -4.9% | 294.2 INR | 309.1 INR | 0.54 | 8.12 | 2.4K | Off |
| 26 Jun 2026 | 328.2 INR | 3.8% | 294.1 INR | 309.0 INR | 0.56 | 14.96 | 0 | Off |
| 19 Jun 2026 | 316.2 INR | 12.6% | 294.1 INR | 308.7 INR | 0.66 | 11.29 | 2.7K | Off |
| 12 Jun 2026 | 280.9 INR | -7.9% | 294.1 INR | 308.5 INR | 0.56 | 0.68 | 9.6K | Off |
| 5 Jun 2026 | 305.0 INR | -0.7% | 294.3 INR | 308.6 INR | 0.53 | 10.63 | 6.0K | Off |
| 29 May 2026 | 307.2 INR | 6.3% | 293.8 INR | 308.5 INR | 0.51 | 10.94 | 86.1K | Off |
| 22 May 2026 | 289.0 INR | 1.8% | 293.4 INR | 308.4 INR | 0.09 | 3.99 | 30.3K | Off |
| 15 May 2026 | 284.0 INR | -5.5% | 293.8 INR | 308.3 INR | -0.32 | 2.78 | 21.1K | Off |
| 8 May 2026 | 300.5 INR | 6.7% | 294.5 INR | 308.3 INR | -0.65 | 6.63 | 83.2K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.